Arrowhead Pharmaceuticals Statistics
NASDAQ: ARWRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
61.48-0.06 (-0.10%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Arrowhead Pharmaceuticals by the numbers
Arrowhead Pharmaceuticals has a market capitalization of $8.68 billion based on 141.25M shares outstanding. With trailing EPS of $-2.28, Arrowhead Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.0% below its 50-day average and 15.2% below its 200-day average.
Average daily trading volume is 1.90M shares, or about $117.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARWR valuation vs. peer median
| Metric | ARWR | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.68B | $8.30B | +5% |
| Avg. volume | 1.90M | 1.50M | +26% |
Peer median across 8 companies: CYTK, AXSM, PTGX, TGTX, ABVX, RDY, SYRE, ALKS.
Valuation
- Market cap
- $8.68B
- Price / sales (latest FY)
- 10.47
- EPS (TTM)
- $-2.28
- Shares outstanding
- 141.25M
Price and trading
- Previous close
- 61.54
- Open
- 61.63
- Day range
- 60.78 – 62.75
- 52-week range
- 34.61 – 95.49
- 52-week change
- +68.25%
- Beta
- —
- Volume
- 1.82M
- Average volume
- 1.90M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 4, 2026
Additional statistics
- Market Cap
- 8.68B
- Forward Pe
- -12.47
- Eps
- -2.28
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 95.49
- Week52 Low
- 34.61
- Avg Volume
- 1.90M
- Shares Outstanding
- 141.25M
- Ma50
- 79.87
- Ma200
- 72.46
- Earnings Date
- Aug 4, 2026
- Pct From52w High
- -35.62%
- Pct From52w Low
- 77.64%